X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs NOVARTIS - Comparison Results

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS NOVARTIS DR. DATSONS LABS/
NOVARTIS
 
P/E (TTM) x -10.9 295.1 - View Chart
P/BV x 0.2 25.1 0.6% View Chart
Dividend Yield % 0.0 1.5 -  

Financials

 DR. DATSONS LABS   NOVARTIS
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
NOVARTIS
Mar-17
DR. DATSONS LABS/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs126855 14.7%   
Low Rs31666 4.6%   
Sales per share (Unadj.) Rs133.0219.0 60.7%  
Earnings per share (Unadj.) Rs0.219.1 0.8%  
Cash flow per share (Unadj.) Rs6.620.3 32.6%  
Dividends per share (Unadj.) Rs010.00 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs128.8307.0 42.0%  
Shares outstanding (eoy) m31.6629.96 105.7%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.5 17.0%   
Avg P/E ratio x516.139.8 1,296.5%  
P/CF ratio (eoy) x11.837.5 31.6%  
Price / Book Value ratio x0.62.5 24.5%  
Dividend payout %052.4 0.0%   
Avg Mkt Cap Rs m2,47722,779 10.9%   
No. of employees `000NA0.7 0.0%   
Total wages/salary Rs m561,393 4.0%   
Avg. sales/employee Rs ThNM9,736.2-  
Avg. wages/employee Rs ThNM2,066.8-  
Avg. net profit/employee Rs ThNM849.0-  
INCOME DATA
Net Sales Rs m4,2116,562 64.2%  
Other income Rs m79702 11.2%   
Total revenues Rs m4,2897,264 59.0%   
Gross profit Rs m569259 219.6%  
Depreciation Rs m20436 569.4%   
Interest Rs m4307 5,975.0%   
Profit before tax Rs m13917 1.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6345 1.8%   
Profit after tax Rs m5572 0.8%  
Gross profit margin %13.53.9 342.3%  
Effective tax rate %48.037.6 127.7%   
Net profit margin %0.18.7 1.3%  
BALANCE SHEET DATA
Current assets Rs m6,8529,731 70.4%   
Current liabilities Rs m6,7111,830 366.6%   
Net working cap to sales %3.3120.4 2.8%  
Current ratio x1.05.3 19.2%  
Inventory Days Days16149 330.4%  
Debtors Days Days31825 1,265.9%  
Net fixed assets Rs m3,67357 6,421.3%   
Share capital Rs m317141 225.0%   
"Free" reserves Rs m3,7619,056 41.5%   
Net worth Rs m4,0789,196 44.3%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63311,499 109.9%  
Interest coverage x1.0128.4 0.8%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.30.6 58.4%   
Return on assets %3.45.0 68.3%  
Return on equity %0.16.2 1.9%  
Return on capital %7.710.1 76.3%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m964129 747.9%   
Fx outflow Rs m6071,734 35.0%   
Net fx Rs m357-1,605 -22.2%   
CASH FLOW
From Operations Rs m1,345-380 -354.4%  
From Investments Rs m-2,2564,208 -53.6%  
From Financial Activity Rs m-1,200-3,318 36.2%  
Net Cashflow Rs m-2,111510 -413.8%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 2.0 -  
FIIs % 1.4 1.6 84.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 21.5 437.7%  
Shareholders   20,807 41,647 50.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ORCHID PHARMA LTD  WYETH LTD  TORRENT PHARMA  ALEMBIC LTD  DR. REDDYS LAB  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS